Related Experiment Videos
Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer
M Onishi1, A L Mui, Y Morikawa
1Department of Cell Signaling, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA 94304, USA.
Abstract:
Thrombopoietin and its receptor (MPL) are important regulators of megakaryopoiesis. We have identified an activating mutation of MPL using a combination of a retrovirus-mediated gene transfer and polymerase chain reaction-driven random mutagenesis. This point mutation causes a single amino acid substitution from Ser498 to Asn498 in the transmembrane region and abrogates factor-dependency of all interleukin-3-dependent cell lines tested. Murine interleukin-3-dependent Ba/F3 cells expressing the mutated but not the normal form of MPL were tumorigenic when transduced into syngeneic mice. Analysis of intracellular signaling pathways indicated that the mutant MPL protein constitutively activated two distinct signaling pathways, SHC-Raf-MAPK and JAK2-STAT3/STAT5.
Insights
A novel activating mutation in MPL, the thrombopoietin receptor, was identified. This mutation leads to constitutive signaling and causes factor-independent cell proliferation and tumorigenicity, impacting megakaryopoiesis regulation.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Thrombopoietin (TPO) and its receptor MPL are crucial for megakaryopoiesis.
- Dysregulation of MPL signaling can contribute to hematological malignancies.
Purpose of the Study:
- To identify activating mutations in the MPL receptor.
- To investigate the functional consequences of MPL mutations on cell signaling and tumorigenicity.
Main Methods:
- Retrovirus-mediated gene transfer and random mutagenesis.
- Analysis of interleukin-3-dependent cell lines (Ba/F3 cells).
- In vivo tumorigenicity assays in syngeneic mice.
- Intracellular signaling pathway analysis (SHC-Raf-MAPK, JAK2-STAT3/STAT5).
Main Results:
- An activating point mutation (Ser498Asn) in the MPL transmembrane region was identified.
- The mutant MPL abrogated factor-dependency in IL-3-dependent cell lines.
- Ba/F3 cells expressing mutant MPL exhibited constitutive activation of SHC-Raf-MAPK and JAK2-STAT3/STAT5 pathways.
- Mutant MPL expression rendered Ba/F3 cells tumorigenic in vivo.
Conclusions:
- The identified MPL mutation promotes constitutive signaling and factor-independent growth.
- This mutation confers tumorigenic potential, highlighting its role in aberrant megakaryopoiesis.
- The findings provide insights into MPL-driven oncogenesis and potential therapeutic targets.